$SLQT Income Statement | Understand Stock

$SLQT

$0.35 +$0.03 (8.04%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Revenue
Service
Production bonus
Pharmacy
Other
Total revenue

OPERATING COSTS AND EXPENSES:
Cost of commissions and other services revenue
Cost of goods sold—pharmacy revenue
Marketing and advertising
General and administrative
Selling, general, and administrative
Technical development
Goodwill impairment
Total operating costs and expenses

INCOME FROM OPERATIONS
INTEREST EXPENSE, NET
CHANGE IN FAIR VALUE OF WARRANTS
LOSS ON EXTINGUISHMENT OF DEBT
OTHER EXPENSE, NET
INCOME (LOSS) BEFORE INCOME TAX EXPENSE
INCOME TAX EXPENSE
NET INCOME (LOSS)
Senior Non-Convertible Preferred Stock accumulated dividends and accretion
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE:
Basic (in dollars per share)
Diluted (in dollars per share)
WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:
Basic (in shares)
Diluted (in shares)
Change in cash flow hedge
Unrealized gain (loss), net of related tax benefit for the year ended June 30, 2026, and 2025, of $0.0 million,and $0.1 million, and tax expense for the year ended June 30, 2024 of $0.3 million.
Net reclassification into earnings
Total change in cash flow hedge
OTHER COMPREHENSIVE LOSS
COMPREHENSIVE INCOME (LOSS)

Comments